一名早产儿的新型冠状病毒肺炎相关呼吸衰竭及瑞德西韦治疗后的结果
SARS-CoV-2 Associated Respiratory Failure in a Preterm Infant and the Outcome after Remdesivir Treatment.
作者信息
Sarhan Mohammed A, Casalino Maria, Paopongsawan Pongsatorn, Gryn David, Kulkarni Tapas, Bitnun Ari, Gauda Estelle B
机构信息
From the Division of Medical Microbiology, Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Canada.
Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Canada.
出版信息
Pediatr Infect Dis J. 2022 May 1;41(5):e233-e234. doi: 10.1097/INF.0000000000003504.
Severe coronavirus disease 2019 (COVID-19) occurs in approximately 10% of neonates infected with severe acute respiratory syndrome coronavirus 2. Guidelines for optimal management of severe COVID-19 in neonates do not exist. In this report, we describe a late-preterm neonate with severe COVID-19, requiring invasive mechanical ventilation who recovered following treatment with remdesivir and high dose dexamethasone.
约10%感染严重急性呼吸综合征冠状病毒2的新生儿会发生重症2019冠状病毒病（COVID-19）。目前尚无关于新生儿重症COVID-19最佳管理的指南。在本报告中，我们描述了一名晚期早产儿患有重症COVID-19，需要有创机械通气，在接受瑞德西韦和高剂量地塞米松治疗后康复。
Zotero 插件